Genitourinary Multidisciplinary Clinic
Comprehensive Genitourinary Treatment
The Genitourinary Multidisciplinary Clinic, a program of the Lifespan Cancer Institute, is entirely dedicated to the compassionate care of patients with urologic malignancies. Our program is certified by the Quality Oncology Practice Initiative and accredited by the prestigious Commission on Cancer of the American College of Surgeons.
Collectively, genitourinary cancers, particularly prostate and bladder cancer, are among the most common form of malignancies, affecting nearly half a million Americans each year. We take a team-based, comprehensive approach, bringing together nationally recognized leaders in the treatment and research of these diseases throughout all phases of the patient’s illness.
Minimally Invasive Treatments
The Lifespan Minimally Invasive Urology Institute is at the forefront of research that has led to breakthrough treatments for patients.
A decade of break-throughs by the Minimally Invasive Urology Institute
At diagnosis, our patients come in for one visit and see physicians in all disciplines, including surgical oncology, medical oncology, diagnostic imaging, critical care medicine, radiation oncology and palliative care. After this initial visit, our team meets with the patient to present a recommended plan of care. Our experienced staff coordinates treatment, as well as all necessary follow-up and rehabilitation, so that patients can focus all their energies on recovery.
Contact the Lifespan Cancer Institute
To learn more or schedule an appointment, please call 1-844-222-2881.
Symptoms of Bladder Cancer
Bladder cancer develops when cells change (mutate) and begin growing uncontrollably. In time, they form a tumor.
Symptoms of Prostate Cancer
Prostate cancer is the most common non-skin cancer in America. One out of nine men will be diagnosed with prostate cancer during their lifetime.
Genitourinary Disorders Research and Clinical Trials
Learn more about the innovative research and treatments for Genitourinary Disorders at the Lifespan Cancer Institute.
